EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype

Journal of Neuroimmunology

Volumn 264, Issue 1-2, 2013, Pages 41-47

  de Carvalho, Samara Camaçari ^a   Apolinário, Leticia Montanholi ^a   Matheus, Selma Maria Michelin ^b   Santo Neto, Humberto ^a   Marques, Maria Julia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Deflazacort; Dystrophy; EPA; Inflammation; M1 macrophages; M2 macrophages

Indexed keywords

ANTIGEN; CD206 PROTEIN; CREATINE KINASE; DEFLAZACORT; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BICEPS BRACHII MUSCLE; CELL POPULATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MALE; MORPHOMETRICS; MOUSE; MUSCLE NECROSIS; MYOSITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; TREATMENT DURATION; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

DEFLAZACORT; DYSTROPHY; EPA; INFLAMMATION; M1 MACROPHAGES; M2 MACROPHAGES;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, DIFFERENTIATION; CREATINE KINASE; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; LECTINS, C-TYPE; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; PREGNENEDIONES; RECEPTORS, CELL SURFACE;

EID: 84886780290     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.09.007     Document Type: Article

References (42)

1. Babcock T.A., Helton W.S., Espat N.J. Eicosapentaenoic acid (EPA): an antiinflamatory ω-3 fat with potential clinical applications. Nutrition 2000, 16:1116-1118.
2. Babcock T.A., Helton W.S., Hong D., Espat N.J. Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-alfa production. Surg. Infect. 2002, 3:145-149.
3. Billiar T., Bankey P., Svingen B., Curran R.D., West M.A., Holman R.T., Simmons R.L., Cerra F.B. Fatty acid uptake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988, 104:343-349.
4. Bushby K., Finkel R., Birnkrant D.J., Case L., Clemens P.R., Cripe L., Kaul A., Kinnett K., McDonald C., Pandya S., Poysky J., Shapiro F., Tomezsko J., Constantin C. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010, 9:177-189.
5. Calder P.C. Fatty acids. Long-chain fatty acids and inflammation. Proc. Nutr. Soc. 2012, 71:284-289.
6. Cullen M.J., Jaros E. Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol. 1988, 77:69-81.
7. Deng B., Wehling-Henricks M., Villalta S.A., Wang Y., Tidball J.G. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J. Immunol. 2012, 189:3669-3680.
8. Engel A.G., Yamamoto M., Fischbeck K.H. Dystrophinopathies. Myology 1994, 1133-1187. McGraw-Hill Inc., New York, NY. G. Engel, C. Franzini-Armstrong (Eds.).
9. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147:3815-3822.
10. Gil Á. Polyunsaturated fatty acids and inflammatory diseases. Biomed. Pharmacother. 2002, 56:388-396.
11. Gorospe J.R., Nishikawa B.K., Hoffman E.P. Recruitment of mast cells to muscle after mild damage. J. Neurol. Sci. 1996, 135:10-17.
12. Hao W., Wong O.Y., Liu X., Lee P., Chen Y., Wong K.K. ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J. Pediatr. Surg. 2010, 45:2412-2418.
13. Hodgetts S., Radley H., Daviers M., Grounds M.D. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking of TNF alpha function with Etanercep in mdx mice. Neuromuscul. Disord. 2006, 16:591-602.
14. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
15. Keeling R.M., Golumbek P.T., Streif E.M., Connolly A.M. Weekly oral prednisolone improves survival and strength in male mdx mice. Muscle Nerve 2007, 35:43-48.
16. Khalfoun B., Thibault F., Watier H., Bardos P., Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv. Exp. Med. Biol. 1997, 400:589-597.
17. Kovalovskya D., Refojoa D., Holsboerc F., Arzta E. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J. Neuroimmunol. 2000, 109:23-29.
18. Lo C.J., Chiu K.C., Fu M., Lo R., Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF-kB activity. J. Surg. Res. 1999, 82:216-221.
19. Machado R.V., Mauricio A.F., Taniguti A.P.T., Ferretti R., Santo Neto H., Marques M.J. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration. J. Neuroimmunol. 2011, 232:145-150.
20. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
21. Manzur A.Y., Kuntzer T., Pike M., Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst. Rev. 2008, 1. CD003725-CD003725.
22. Marques M.J., Oggiam D.S., Barbin I.C., Ferretti R., Santo Neto H. Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice. Muscle Nerve 2009, 40:466-468.
23. Matsumoto T., Nakayama N., Ishida K., Kobayashi T., Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of Type 2 diabetes. J. Pharmacol. Exp. Ther. 2009, 329:324-334.
24. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011, 17:2-15.
25. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209-212.
26. Muls N., Jnaoui K., Dang H.A., Wauters A., Van Snick J., Jean-Marie Sindic C., van Pesch V. Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network. J. Neuroimmunol. 2012, 243:73-80.
27. Payne E.T., Yasuda N., Bourgeois J.M., Devries M.C., Rodriguez M.C., Yousuf J., Tarnopolsky M.A. Nutritional therapy improves function and complements corticosteroid intervention in mdx mice. Muscle Nerve 2006, 33:66-77.
28. + population and cytokine-producing cells in rheumatoid arthritis. Rheumatology 2012, 51:1198-1207.
29. Porter J.D., Khanna S., Kaminski H.J., Rao J.S., Merriam A.P., Richmonds C.R., Leahy P., Li J., Guo W., Andrade F.H. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 2002, 11:263-272.
30. Radley H.G., Grounds M.D. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiol. Dis. 2006, 23:387-397.
31. Radley H.G., De Luca A., Lynch G.S., Grounds M.D. Medicine in focus: Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int. J. Biochem. Cell Biol. 2007, 39:469-477.
32. Satoh-Asahara N., Shimatsu A., Sasaki Y., Nakaoka H., Himeno A., Tochiya M., Kono S., Takaya T., Ono K., Wada H., Suganami T., Hasegawa K., Ogawa Y. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012, 35:2631-2639.
33. Serini S., Bizzarro A., Piccioni E., Fasano E., Rossi C., Lauria A., Cittadini A.R.M., Masullo C., Calviello G. EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients. Curr. Alzheimer Res. 2012, 9:913-923.
34. Stedman H.H., Sweenwey H.L., Shrager J.B., Maguire H.C., Panettieri R.A., Petrof B., Narusawa M., Leferovich J.M., Sladky J.T., Kelly A.M. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539.
35. Strle K., McCusker R.H., Tran L., King A., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts. J. Neuroimmunol. 2007, 188:48-55.
36. Tidball J.G. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R345-R353.
37. Villalta S.A., Nguyen H.X., Deng B., Gotoh T., Tidball J.G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 2009, 18:482-496.
38. Villalta S.A., Deng B., Rinaldi C., Wehling-Henricks M., Tidball J.G. IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J. Immunol. 2011, 187:5419-5428.
39. Villalta S.A., Rinaldi C., Deng B., Lui G., Fedor B., Tidball J.G. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivation M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet. 2011, 20:709-805.
40. Wehling-Henricks M., Jordan M.C., Gotoh T., Godoy W.W., Roos K.P., Tidball J.G. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One 2010, 5:e10763.
41. Whitehead N.P., Yeung E.W., Allen D.G. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin. Exp. Pharmacol. Physiol. 2006, 33:657-662.
42. Yaqoob P., Calder P.C. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell. Immunol. 1995, 163:120-128.